Mia's Feed
Medical News & Research

Innovative Tool Enhances Seizure Prediction and Optimizes EEG Machine Use in Hospitals

Innovative Tool Enhances Seizure Prediction and Optimizes EEG Machine Use in Hospitals

Share this article

A groundbreaking AI-based scoring system enhances seizure prediction, enabling faster decision-making and better resource allocation in hospitals' intensive care units.

3 min read

In hospital intensive care units, neurologists traditionally rely on a straightforward scorecard to quickly assess the risk of brain-damaging seizures in critically ill patients. This approach helps in preventing seizures, saving lives, reducing healthcare costs, and making the best use of limited expensive medical equipment.

Prior to 2019, hospitals lacked efficient means to monitor brain activity continuously and accurately forecast seizures. Typically, patients required 24 to 48 hours of continuous EEG (cEEG) monitoring, which is costly and resource-intensive. Due to the limited number of cEEG machines, hospitals could only monitor a few patients at a time, often prioritizing low-risk individuals while higher-risk patients waited.

The breakthrough came from a 2016 project led by Duke University engineer Cynthia Rudin, along with Ph.D. student Berk Ustun and neurologists Aaron Struck and Brandon Westover. Using artificial intelligence, the team analyzed data from over 5,000 patients to develop a new risk assessment tool named "2HELPS2B." This scorecard evaluates various patterns in a patient’s brain activity data to estimate seizure likelihood, assigning probabilities from 5% to 95%.

This innovative model utilizes machine learning algorithms that consider around 70 factors derived from cEEG readings. The process—once taking up to two days—has been reduced to just 60 minutes, significantly speeding up clinical decision-making. The simplicity of the scorecard, which involves straightforward tallying of small numbers (1s and 2s), enables widespread use across hospitals.

The scoring system assigns points based on specific electrical patterns in the brain and prior seizure history. A score of zero indicates a very low seizure risk, while higher scores prompt more immediate intervention. For example, a score of 6 or more signals a high likelihood of seizure, guiding physicians to prioritize resources efficiently.

The practical application of this tool has shown substantial benefits. A 2025 study from UNC Chapel Hill demonstrated that employing the scorecard allows hospitals to reallocate EEG monitoring resources effectively without compromising seizure detection accuracy. This leads to better patient care and more efficient utilization of expensive medical equipment.

Neurologists emphasize the tool’s ease of use, noting that it does not require complex calculations—just simple addition. Consequently, it has become a standard in ICUs, with estimates suggesting that over 90% of hospitals with ICU EEG capabilities utilize this scoring method.

Funded publicly by the government, the development and dissemination of the 2HELPS2B scorecard highlight the importance of accessible medical innovations. Its open availability enables hospitals and medical staff worldwide to improve seizure management and patient prognosis.

Overall, this AI-driven tool marks a significant advancement in critical care, aiding doctors in making faster, more accurate decisions to prevent brain injuries caused by seizures.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Work Requirements and Bureaucratic Challenges for Millions on Medicaid

New Medicaid work requirements in many states are creating confusing processes, risking loss of coverage for millions. Experts warn about increased red tape and systemic hurdles that hinder access to essential health coverage.

Biological Aging Faster in Rwandans Conceived During Genocide: New Research Findings

Recent research reveals that individuals conceived during Rwanda's 1994 genocide are experiencing accelerated biological aging, particularly among those born of genocidal rape, emphasizing the need for targeted healthcare and long-term support.

Combination of Chemotherapy and Natural Extract Castalin Enhances Cancer Treatment Effectiveness

New study shows that combining chemotherapy with natural extract castalin from chestnuts can boost cancer treatment effectiveness and reduce side effects, offering hope for improved therapies.

Research Confirms Diets Are Ineffective for Managing Lipoedema Fat in Women

New research confirms that traditional diets are ineffective in reducing fat caused by lipoedema in women. A study from NTNU highlights the limited impact of dieting and explores the benefits of low-carb diets for symptom relief and weight loss. Learn more about managing this challenging condition.